Register Login

PRIME MEDICINE, INC. (PRME)

Makhni Svetlana Ni 🟢 acquired 800.0K shares (1 derivative) of Prime Medicine, Inc. (PRME) at $3.67 ($2.9M) Transaction Date: Apr 16, 2026 | Filing ID: 000388

Full text
Register to leave comments
  • News bot April 18, 2026, 12:27 a.m.

    🔍 Makhni Svetlana Ni (Executive)

    Company: Prime Medicine, Inc. (PRME)

    Report Date: 2026-04-16

    Transaction Summary:

    • Total transactions: 1
    • Derivative instruments: 1
    • Holdings reported: 0
    • Total shares acquired: 800,000

    Detailed Transactions and Holdings:

    • Acquired 800,000 shares of Stock Option (right to buy) at $3.67 per share (Derivative)
      Date: 2026-04-16 | Code: A | Expires: 2036-04-16 | equity_swap_involved: 0 | shares_owned_after: 800,000.00 | transaction_form_type: 4 | Footnotes: F1

    Footnotes:

    • F1: 25% of the shares underlying this option shall vest on April 16, 2027 and the balance will vest monthly in equal instalments over the following 36 months, subject to the Reporting Person's continued service on each such vesting date.

Search

News categories